Show simple item record

dc.creatorWolfe, Sidney M.en
dc.date.accessioned2016-03-18T17:38:55Zen
dc.date.available2016-03-18T17:38:55Zen
dc.date.created1996-10en
dc.date.issued1996-10en
dc.identifierdoi:10.1007/BF02599033en
dc.identifier.bibliographicCitationJournal of General Internal Medicine 1996 October; 11(10): 637-639en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Why+Do+American+Drug+Companies+Spend+More+than+$12+Billion+a+Year+Pushing+Drugs?+Is+it+Education+or+Promotion?;+Characteristics+of+Materials+Distributed+by+Drug+Companies:+Four+Points+of+View&title=Journal+of+General+Internal+Medicine+&volume=11&issue=10&spage=637-639&date=1996-10&au=Wolfe,+Sidney+M.en
dc.identifier.urihttp://dx.doi.org/10.1007/BF02599033en
dc.identifier.urihttp://hdl.handle.net/10822/1037789en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:168415en
dc.subjectDrugsen
dc.subjectEducationen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationBusiness Ethicsen
dc.subject.classificationEconomics of Health Careen
dc.titleWhy Do American Drug Companies Spend More Than $12 Billion a Year Pushing Drugs? Is It Education or Promotion? Characteristics of Materials Distributed by Drug Companies: Four Points of Viewen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2023 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885